Original document(12 pages)  中文版
    The present invention belongs to the field of pharmaceutical technology and relates to transdermal Ligustrazine plaster and its preparation. It has Ligustrazine phosphate or Ligustrazine as active medicinal component and consists of medicine storing back, adhering layer, release controlling film, back lining layer and protective layer. It is superior to available Ligustrazine preparation forms in medicine releasing are, transdermal rate and lasting release time, and has the features of determined curative effect, stable quality, high safety, etc. Animal experiments show that the plaster can retard the effect of ischemic to cerebral damage, inhibit thrombosis caused by tissue damage, prevent and treat cerebral embolism and maintain balanced medicine density in blood for 24 hr; and has light irritation to skin, no irritability and no toxic reaction.
Application Number
申请号
02157693 Application Date
申请日
2002.12.24
Title 名称 Transdermal Ligustrazine plaster and its prepn
Publication Number
公开号
1432363 Publication Date
公开日
2003.07.30
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/70,A61K31/4965,A61M37/00,A61P9/10
Applicant(s) Name
申请人
Fudan Univ.
Address 地址 200433
Inventor(s) Name 发明人 Shen Teng, Xu Huinan
Attorney & Agent 代理人 bao zhaoyi
More information 更  多  信  息


 Related patents information
Bulley aconitne transdermal paster
Skin penetrating paste containing ligustrazine free alkali and its preparation
Erigeron breviscapus extraction dry suspensoid agent
Felt wort extract, its preparation method and use
Heparin oral nano composition and its preparation method
Effervescent dry-mixed suspension agent
Erigeron breviscapus effervescent dry mixed suspension and its making method
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.